The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Protagonist Therapeutics Inc’s current trading price is -25.99% away from its 52-week high, while its distance from the 52-week low is 85.18%. The stock’s price range for this period has been between $24.22 and $60.60 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.86 million for the day, a number notably lower than the average daily volume of 1.18 million over the last three months.
In terms of market performance, Protagonist Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $60.60 on 03/12/25, and the lowest value was recorded at $24.22 on 04/26/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Protagonist Therapeutics Inc (PTGX) has experienced a quarterly rise of 18.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.75B and boasts a workforce of 126 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 42.18, with a change in price of +0.02. Similarly, Protagonist Therapeutics Inc recorded 968,327 in trading volume during the last 100 days, posting a change of +0.04%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PTGX stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.02.
PTGX Stock Stochastic Average
As of today, Protagonist Therapeutics Inc’s raw stochastic average for the last 50 days stands at 41.45%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 48.07%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 49.45% and 47.63%, respectively.
PTGX Stock Price Performance Analysis
The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The metric has seen a significant gain of 16.19% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -2.42%. Over the past 30 days, the price of PTGX has leaped by -12.14%. And in the last five days, it has fallen by -2.07%.
